Abeona Therapeutics is a Dallas-based biopharmaceutical company dedicated to delivering cell and gene therapies for individuals affected by serious diseases. With a focus on rare genetic disorders, their pipeline includes investigational treatments for conditions such as recessive dystrophic epidermolysis bullosa (RDEB) and genetic eye disorders.
Driven by their mission to provide innovative solutions, Abeona Therapeutics is actively engaged in clinical trials and manufacturing at The Elisa Linton Center for Rare Disease Therapies. Their commitment to patient advocacy and community engagement further underscores their dedication to improving the lives of those impacted by these challenging conditions.
Generated from the website